No description

Treat me like a lady

Problem

Medical science is almost entirely based on men, with life-threatening consequences for women. How can we put pressure on the government to create change?

Solution

Put pressure on medical stakeholders by asking for the support of the press and the public to speed up the process of change by demanding a decency standard that is both logical and necessary – Treat me like a lady.

Creative

By informing the public and media through hard, surprising facts like ‘women have a 60 percent higher chance to get side effects from medication than men’ and ‘signs of a heart attack differ between men and women’, women could lobby their doctors for change themselves. These messages are spread online with an urgent request to share further. Through the pressure of this campaign, the Dutch health minister provided 12 million Euros for further research on this topic. The campaign was awarded a bronze Effie (effectiveness award).

No description
No description
No description
No description
No description
No description

More WOMEN Inc.

No description
Doorbreek De Cyclus: HMB
No description
Doorbreek De Cyclus
No description
It's Not Working
No description
15% less - Women Inc.
No description
Introducing the Biggest Enterprise of The Netherlands
No description
Het Verdienmodel
No description
WOMEN inc. - Komt een mens bij de dokter
No description
WOMEN Inc. - Equal Pay Day
No description
WOMEN Inc. - Limited view
No description
Women inc - explaining 100 years of women’s suffrage with cake
No description
WOMEN Inc. - Migraine
No description
WOMEN Inc. - Pay gap
No description
WOMEN Inc. - I'm not here
No description
WOMEN Inc. - Treat me like a lady

Want to know more, or ask us something?

KesselsKramer invites you to

Sign up to our new newsletter for new work, ideas, thoughts, feelings and the odd rumour.

Have a similar project, problem or communication-need laying about? Would you like us to help? Or, simply like the look of our work and want to know more, get in contact below.

  • This field is for validation purposes and should be left unchanged.
+
NEWSLETTER
+
NEWSLETTER

Subscribe to our newsletter